⚡️👀 NEW - FDA approves breakthrough eye drops that fix near vision without glasses

The FDA has approved VIZZ, revolutionary eye drops for presbyopia without glasses. The innovative active ingredient aceclidine creates a “pinhole effect” by gently constricting the pupil and improving near vision for ten hours. Unlike previous treatments, it does not affect the focusing muscles, thereby avoiding side effects such as blurred distance vision.

The approval is based on three Phase II studies with over 30,000 treatment days without serious side effects. VIZZ will be available at the end of 2025 and could become the new standard for the more than 128 million Americans affected. "This pupil-selective technology marks a significant breakthrough in the non-invasive treatment of age-related vision problems."